Investigators screened B cells from COVID-19 donors and identify P5C3, a highly potent and broadly neutralizing monoclonal antibody with picomolar neutralizing activity against all SARS-CoV-2 variants of concern identified to date.
[Cell Reports]
6445218
{6445218:AAAAAAAA}
apa
50
1
167079
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/